NNLX

NanoLogix, Inc. NNLX

NNLX
NanoLogix, Inc. SCPS
Scopus BioPharma Inc. PXMD
PaxMedica, Inc. Common Stock VAXX
Vaxxinity, Inc. GNLKQ
GeneLink, Inc. TRVN
Trevena, Inc. QBIO
Q BioMed Inc. NAVB
Navidea Biopharmaceuticals, Inc. EHOS
Ehouse Global, Inc. VOQP
VioQuest Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NNLX SCPS PXMD VAXX GNLKQ TRVN QBIO NAVB EHOS VOQP
6M 0.00 % 0.00 % 0.00 % -90.00 % -60.00 % -98.98 % 0.00 % -83.33 % 0.00 % 0.00 %
YTD 0.00 % 0.00 % -99.85 % -80.00 % -60.00 % -99.25 % 9 900.00 % 0.00 % 900.00 % 0.00 %
1Y 900.00 % -25.00 % -99.93 % -50.00 % -60.00 % -99.49 % 9 900.00 % -80.00 % 900.00 % 0.00 %
3Y -50.00 % -99.88 % -100.00 % -99.94 % -60.00 % -99.99 % -99.31 % -99.96 % -90.00 % 0.00 %
5Y -99.82 % -99.99 % -100.00 % -99.99 % -94.29 % -100.00 % -99.99 % -100.00 % 99 900.00 % 50.00 %
10Y -99.62 % -99.99 % -100.00 % -99.99 % -86.67 % -100.00 % -100.00 % -100.00 % -99.90 % -92.50 %
From the beginning -99.97 % -99.99 % -100.00 % -99.99 % -100.00 % -100.00 % -99.98 % -100.00 % -66.67 % -100.00 %

Dividend